Table 3.

Treatment duration and relative dose intensity according to frailty score

Parameter	Frail (n = 40)	Fit/intermediate (n = 29)	Missing frailty score (n = 51)
Therapeutic agents for RRMM
Isatuximab
Average single dose, mg/day, median (range)	10.0 (9.0, 10.0)	10.0 (10.0, 10.0)	10.0 (8.5, 10.0)
Treatment durationa, days median (range)	72.0 (1.0, 228.0)	97.0 (8.0, 220.0)	82.0 (1.0, 223.0)
Pomalidomide
Average single dose, mg/day, median (range)	2.35 (1.0, 4.0)	3.07 (1.1, 4.0)	4.0 (1.0, 4)
Treatment durationa, days median (range)	83.0 (1.0, 316.0)	110.0 (8.0, 294.0)	98.5 (1.0, 301.0)
Dexamethasone
Average single dose, mg/day, median (range)	20.0 (4.0, 40.0)	29.4 (8.0, 40.0)	20.0 (3.3, 40.0)
Treatment durationa, days median (range)	74.0 (1.0, 294.0)	93.0 (8.0, 730.0)	88.0 (1.0, 323.0)

RRMM, relapsed or refractory myeloma

^aExcludes rest days